RESOTHER PHARMA A/S
Desconocido
CardioProtectMI: A new cardioprotective drug for acute treatment of myocardial infarction
RESOTHER PHARMA AS
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2023-ACCELERATOR-01
Ischemic Heart Disease kills more than 1.7M people/year in the EU, the vast majority via a heart attack (Myocardial Infarction - MI). Heart...
2024-02-27 - 2026-01-31 | Financiado
2024-02-27 - 2026-01-31 | Financiado
CardioProtectMI: A New Drug Therapy for the treatment of ST Elevated Myocardial Infarction
RESOTHER PHARMA AS
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Ischaemic heart disease (IHD) is the leading cause of mortality in Europe with about 1.8 million reported deaths per year in
Europe alone. A...
2019-11-29 - 2020-02-29 | Financiado
2019-11-29 - 2020-02-29 | Financiado
* No se disponen de datos de la empresa actual.